Abstract

BackgroundEmerging evidence suggests that circular RNAs play critical roles in disease development especially in cancers. Previous genome-wide RNA-seq studies found that a circular RNA derived from SOD2 gene was highly upregulated in hepatocellular carcinoma (HCC), however, the role of circSOD2 in HCC remains largely unknown.MethodsThe expression profiling of circSOD2 and microRNA in HCC patients were assessed by Real-Time Quantitative Reverse Transcription PCR (qRT-PCR). SiRNA or CRISPR-CAS9 were used to silence gene expression. The biological function of circSOD2 in HCC was investigated using in vitro and in vivo studies including, trans-well cell migration, cell apoptosis, cell cycle, CCK8, siRNA interference, western blots, and xenograft mouse model. The underlying molecular mechanism was determined by Chromatin Immunoprecipitation quantitative real time PCR (ChIP-qPCR), bioinformatic analysis, biotin-pull down, RNA immunoprecipitation, 5-mc DNA pulldown and luciferase assays.ResultsIn accordance with previous sequencing results, here, we demonstrated that circSOD2 was highly expressed in HCC tumor tissues compared with normal liver tissues. Mechanically, we showed that histone writer EP300 and WDR5 bind to circSOD2 promoter and trigger its promoter H3K27ac and H3K4me3 modification, respectively, which further activates circSOD2 expression. SiRNA mediated circSOD2 suppression impaired liver cancer cell growth, cell migration, prohibited cell cycle progression and in vivo tumor growth. By acting as a sponge, circSOD2 inhibits miR-502-5p expression and rescues miR-502-5p target gene DNMT3a expression. As a DNA methyltransferase, upregulated DNMA3a suppresses SOCS3 expression by increasing SOCS3 promoter DNA methylation. This event further accelerates SOCS3 downstream JAK2/STAT3 signaling pathway activation. In addition, we also found that activated STAT3 regulates circSOD2 expression in a feedback way.ConclusionThe novel signaling axis circSOD2/miR-502-5p/DNMT3a/JAK2/STAT3/circSOD2 provides a better understanding of HCC tumorigenesis. The molecular mechanism underlying this signaling axis offers new prevention and treatment of HCC.

Highlights

  • Emerging evidence suggests that circular RNAs play critical roles in disease development especially in cancers

  • CircSOD2 is highly expressed in hepatocellular carcinoma (HCC) tumor tissues and liver cancer cell lines Genome-wide RNA-seq studies on HCC tumor tissues and their adjacent nontumorous liver tissues revealed that hsa_circ_0004662, derived from SOD2 gene was significantly upregulated in HCC tumor tissues [26]

  • (See figure on previous page.) Fig. 1 CircSOD2 is highly expressed in HCC tumor tissues and liver cancer cell lines. a Demonstration of circSOD2 formation, F and R are divergent primers used for circSOD2 detection. b RT-qPCR results of circSOD2 expression in 19 HCC patient tumor tissues and adjacent normal liver tissues

Read more

Summary

Introduction

Emerging evidence suggests that circular RNAs play critical roles in disease development especially in cancers. Previous genome-wide RNA-seq studies found that a circular RNA derived from SOD2 gene was highly upregulated in hepatocellular carcinoma (HCC), the role of circSOD2 in HCC remains largely unknown. Hepatocellular carcinoma (HCC) accounts for > 80% of liver cancer cases and is the fourth leading cause of cancer-related death worldwide [1, 2]. Despite great advances have been made in the early diagnosis and treatment, the prognosis of HCC patients is still low due to late diagnosis, recurrence and late stage metastasis [5]. The underlying molecular mechanism remains largely unknown. Identifying new molecular target or mechanism that drive HCC development will help us understand its pathogenesis and provide new therapeutic methods

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call